ReposiTrak, Inc. Q3 FY2025 earnings call

• The company aims for 10-20% annual revenue growth and faster profitability growth. • Traceability is unfolding as expected, with the FDA extending the enforcement deadline providing more time for smooth onboarding. • Automation via the wizard is growing, with two-thirds of new traceability customers joining through the automated wizard. • Cross-selling initiatives are gaining momentum as customers expand to other solutions on the single platform. • Capital allocation strategy involves returning 50% of annual cash from operations to shareholders and building cash on the balance sheet.

Total revenue for the third fiscal quarter 2025 was $5.9 million, an increase of 16% compared to the prior year's $5.1 million. Recurring revenue in the third quarter was $5.8 million, up 15%. For the fiscal year to date, total revenue reached $16.8 million, a 10.3% increase from the prior year's $15.3 million, and recurring revenue year-to-date was $16.6 million, up 9%. While specific segment revenue contributions by percentage aren't detailed, the overall growth across traceability, compliance, and supply chain lines of business is emphasized.

• The company is confident in maintaining 10-20% annual top line revenue growth. • Aims to increase profitability, with goals of 80% gross margins and 30% net margins over the next several years. • Intends to continue returning capital to shareholders through dividends, stock repurchases, and preferred stock redemptions.

• Uncertainty from tariffs, which can introduce hurdles and slow down the food industry. • Regulatory and market uncertainties that may impact the pace of adoption of traceability and other solutions.

Q: Can you talk about the impact of tariffs on your business?

A: Tariffs introduce uncertainty, which can slow down the food industry, but no significant negative impact has been observed in ReposiTrak's business thus far.

Q: How should we think about changes in cost structure and next dollar revenue conversion to profitability?

A: The company will continue investing in automation to flatten expenses over time, with the goal of increasing the contribution margin from incremental revenue to 70-80%.

Q: Talk about cross-selling products and growth of other initiatives?

A: With a single platform, customers are likely to expand as they share pain points, and the platform's operating leverage and customer relationships drive cross-selling.

Q: Build versus buy decision making process?

A: The company prefers building on its platform due to its uniqueness and ability to quickly develop applications, and is selective about acquisitions, focusing on domain knowledge and customer acquisition.

Q: When do you expect to become full taxpayers and what rate?

A: There are net operating losses to work through, and specific rate details will be provided in future calls as tax incentives are evaluated.

Q: Talk about new products over the next couple years?

A: New products will focus on adjacencies to existing services like recall management, ordering, and forecasting, leveraging the single platform for higher margins.